# Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure

> **NCT03871699** · PHASE4 · UNKNOWN · sponsor: **Hospital Moinhos de Vento** · enrollment: 20 (estimated)

## Conditions studied

- Cardiac Failure
- Systolic Heart Failure
- Heart Failure, Systolic

## Interventions

- **DRUG:** Ferric carboxymaltose

## Key facts

- **NCT ID:** NCT03871699
- **Lead sponsor:** Hospital Moinhos de Vento
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-30
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-02-28
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03871699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03871699, "Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03871699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*